Haug AR - Search Results

1

Response and Toxicity to the Second Course of 3 Cycles of ¹⁷⁷Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.

Rasul S, Wollenweber T, Zisser L, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Eidherr H, Mitterhauser M, Vraka C, Langsteger W, Hacker M, Haug AR. Rasul S, et al. Among authors: haug ar. Cancers (Basel). 2021 May 20;13(10):2489. doi: 10.3390/cancers13102489. Cancers (Basel). 2021. PMID: 34065303 Free PMC article.

2

Detection of low-grade prosthetic joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results.

Graute V, Feist M, Lehner S, Haug A, Müller PE, Bartenstein P, Hacker M. Graute V, et al. Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1751-9. doi: 10.1007/s00259-010-1431-3. Epub 2010 Mar 23. Eur J Nucl Med Mol Imaging. 2010. PMID: 20309680

3

68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.

Haug AR, Auernhammer CJ, Wängler B, Schmidt GP, Uebleis C, Göke B, Cumming P, Bartenstein P, Tiling R, Hacker M. Haug AR, et al. J Nucl Med. 2010 Sep;51(9):1349-56. doi: 10.2967/jnumed.110.075002. Epub 2010 Aug 18. J Nucl Med. 2010. PMID: 20720050 Free article.

4

18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.

Haug AR, Heinemann V, Bruns CJ, Hoffmann R, Jakobs T, Bartenstein P, Hacker M. Haug AR, et al. Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1037-45. doi: 10.1007/s00259-011-1736-x. Epub 2011 Feb 10. Eur J Nucl Med Mol Imaging. 2011. PMID: 21308371

5

Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy.

Uebleis C, Hellweger S, Laubender RP, Becker A, Sohn HY, Lehner S, Haug A, Bartenstein P, Cumming P, Van Kriekinge SD, Slomka PJ, Hacker M. Uebleis C, et al. Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1561-9. doi: 10.1007/s00259-012-2157-1. Epub 2012 Jul 3. Eur J Nucl Med Mol Imaging. 2012. PMID: 22752450

6

Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Fendler WP, Philippe Tiega DB, Ilhan H, Paprottka PM, Heinemann V, Jakobs TF, Bartenstein P, Hacker M, Haug AR. Fendler WP, et al. Among authors: haug ar. J Nucl Med. 2013 Aug;54(8):1202-8. doi: 10.2967/jnumed.112.116426. Epub 2013 May 31. J Nucl Med. 2013. PMID: 23729697 Free article.

7

Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.

Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Bartenstein P, Hacker M, Haug AR. Ilhan H, et al. Among authors: haug ar. J Nucl Med. 2015 Mar;56(3):333-8. doi: 10.2967/jnumed.114.150565. Epub 2015 Feb 5. J Nucl Med. 2015. PMID: 25655623 Free article.

8

Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Fendler WP, Ilhan H, Paprottka PM, Jakobs TF, Heinemann V, Bartenstein P, Khalaf F, Ezziddin S, Hacker M, Haug AR. Fendler WP, et al. Among authors: haug ar. Eur Radiol. 2015 Sep;25(9):2693-700. doi: 10.1007/s00330-015-3658-7. Epub 2015 Feb 28. Eur Radiol. 2015. PMID: 25721320

9

Role of (64)CuCl 2 PET/CT in staging of prostate cancer.

Capasso E, Durzu S, Piras S, Zandieh S, Knoll P, Haug A, Hacker M, Meleddu C, Mirzaei S. Capasso E, et al. Ann Nucl Med. 2015 Jul;29(6):482-8. doi: 10.1007/s12149-015-0968-4. Epub 2015 Apr 2. Ann Nucl Med. 2015. PMID: 25833290

10

Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.

Leisser A, Pruscha K, Ubl P, Wadsak W, Mayerhöfer M, Mitterhauser M, Hacker M, Kramer G, Shariat S, Karanikas G, Hartenbach M, Haug AR. Leisser A, et al. Among authors: haug ar. Prostate. 2015 Nov;75(15):1760-7. doi: 10.1002/pros.23061. Epub 2015 Aug 18. Prostate. 2015. PMID: 26282590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page